Chat
Hepatitis B Virus Surface Antibody
Copy Utility
Ordering Recommendation
Monitor post-liver-transplant therapy with hepatitis B immunoglobulin in HBV-positive patients and ascertain response to HBV vaccines.
Mnemonic
Methodology
Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
Specimen Required
Serum separator tube. Also acceptable: Lavender (EDTA) or pink (K2EDTA).
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
Heparinized plasma. Specimens containing particulate material. Heat-inactivated , severely hemolyzed, or lipemic specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
Reference Interval
| Less than 10.00 IU/L | Negative |
| Greater than or equal to 10.00 IU/L | Positive |
Interpretive Data
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
FDA
Note
Results greater than 1,000.00 IU/L are reported as greater than 1,000.00 IU/L
Hotline History
CPT Codes
86706
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0020090 | Hepatitis B Surface Antibody | 5193-8 |
Aliases
- Anti-HBs Titer, S
- Anti-Hepatitis Bs
- Antibody Titer to Hep B Surface Ag
- Antibody to Hepatitis B Surface Antigen
- HBsAB
- HBV Hep B Surface Ab
- Hepatitis B Immunity
- Hepatitis B Surface Antibody, Quantitative
- Hepatitis Bs
Feedback
